X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Pfizer with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs ADCOCK INGRAM (S. Africa) - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PFIZER   ADCOCK INGRAM
EQUITY SHARE DATA
    PFIZER
Mar-16
ADCOCK INGRAM
Jun-14
PFIZER/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs2,724381-   
Low Rs1,611275-   
Sales per share (Unadj.) Rs440.9113.4-  
Earnings per share (Unadj.) Rs48.7-28.6-  
Cash flow per share (Unadj.) Rs75.8-23.7-  
Dividends per share (Unadj.) Rs15.000-  
Dividend yield (eoy) %0.70-  
Book value per share (Unadj.) Rs462.989.0-  
Shares outstanding (eoy) m45.75168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.92.9 169.9%   
Avg P/E ratio x44.5-11.5 -387.6%  
P/CF ratio (eoy) x28.6-13.9 -206.5%  
Price / Book Value ratio x4.73.7 127.0%  
Dividend payout %30.80-   
Avg Mkt Cap Rs m99,16355,398 179.0%   
No. of employees `0002.94.3 67.3%   
Total wages/salary Rs m2,7583,477 79.3%   
Avg. sales/employee Rs Th6,981.74,459.9 156.5%   
Avg. wages/employee Rs Th954.5809.9 117.9%   
Avg. net profit/employee Rs Th771.1-1,123.8 -68.6%   
INCOME DATA
Net Sales Rs m20,17019,146 105.3%  
Other income Rs m857134 639.5%   
Total revenues Rs m21,02819,280 109.1%   
Gross profit Rs m4,310-3,318 -129.9%  
Depreciation Rs m1,239826 149.9%   
Interest Rs m5519 1.0%   
Profit before tax Rs m3,923-4,529 -86.6%   
Minority Interest Rs m0-13 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m990-   
Tax Rs m1,794283 634.1%   
Profit after tax Rs m2,228-4,824 -46.2%  
Gross profit margin %21.4-17.3 -123.3%  
Effective tax rate %45.7-6.2 -732.0%   
Net profit margin %11.0-25.2 -43.8%  
BALANCE SHEET DATA
Current assets Rs m16,29914,023 116.2%   
Current liabilities Rs m7,5947,890 96.2%   
Net working cap to sales %43.232.0 134.7%  
Current ratio x2.11.8 120.8%  
Inventory Days Days65111 58.9%  
Debtors Days Days26124 20.8%  
Net fixed assets Rs m8,6228,174 105.5%   
Share capital Rs m45889 514.7%   
"Free" reserves Rs m20,7220-   
Net worth Rs m21,18015,028 140.9%   
Long term debt Rs m255,281 0.5%   
Total assets Rs m29,13728,389 102.6%  
Interest coverage x755.5-7.7 -9,770.5%   
Debt to equity ratio x00.4 0.3%  
Sales to assets ratio x0.70.7 102.6%   
Return on assets %7.7-15.2 -50.5%  
Return on equity %10.5-32.1 -32.8%  
Return on capital %19.0-19.8 -95.9%  
Exports to sales %0.10-   
Imports to sales %17.50-   
Net fx Rs m-880-   
CASH FLOW
From Operations Rs m3,4361,634 210.3%  
From Investments Rs m-6,991-502 1,393.2%  
From Financial Activity Rs m-6194,793 -12.9%  
Net Cashflow Rs m-4,1745,925 -70.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.26 Rs / ZAR

Compare PFIZER With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare PFIZER With: WOCKHARDT LTD.  DR. REDDYS LAB  LUPIN LTD  SUVEN LIFE  ALKEM LABORATORIES  



Today's Market

Sensex Breaches 36,000 Mark; ONGC Nears 52-Week High(Closing)

The NSE Nifty on Tuesday sailed past the 11,000 mark, while the BSE Sensex breached the 36,000 level for the first time after an IMF report showed India was set to regain.

Related Views On News

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Jan 23, 2018 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS